2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO37] Mini-Oral Session 37　Cross-sectional Program 3（Clinical practice of immuno-check point inhibitor）
【E】

Sat. Feb 19, 2022 8:20 AM - 9:10 AM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Yasumasa Nishimura（Department of Radiation Oncology, Kindai University），Masato Masuda（Cancer Centre, University of the Ryukyus Hospital）

[MO37-2] Retrospective study of the efficacy and safety of Pembrolizumab for solid tumors with MSI-High

○Takako Ikegami1, Fukutaro Shimamoto1, Masahiro Goto1, Tetusuji Terazawa1, Eiki Yamasaki1, Kazuhide Higuchi2 (1.Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University Hospital, 2.Osaka Medical and Pharmaceutical University, 2nd Department of Internal Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password